drugset
drugset / Trial / NCT00652886

Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions

NCT00652886 ↗

Phase 1 Completed 26 enrolled Par Pharmaceutical, Inc. Cetero Research, San Antonio · collab
RandomizedCrossoverOpen-label

Summary

-To compare the single dose bioavailability of Kali and BTG

Timeline

Start
2005-03
Primary completion
2005-03
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxandrolone Small molecule 10 mg —

Indications

No indication recorded.